IPO registrations (S-1, F-1) · Registrants
BIOCEPT INC
- SEC CIK
- 1044378 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2013-09-23, last 2023-05-23; 11 initial registrations, 32 amendments
- Outcome
- Final prospectus filed 2014-02-06; declared effective 2014-02-04
- Industry (SIC)
- Services-Medical Laboratories 8071
- Incorporated in
- DE
- Business address
- 9955 MESA RIM ROAD, San Diego, CA 92121
- EIN
- 80-0943522
- EDGAR entity type
- operating
- Insiders and CEO pay
- BIOCEPT INC on the corporate pages
On this site
- Business registration: BIOCEPT, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Biocept, Inc. Fuzzy (name and state)
- Business registration: Biocept, Inc. Fuzzy (name and state)
- Business registration: BIOCEPT, INC. Fuzzy (name and state)
- Business registration: BIOCEPT, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: BIOCEPT, INC. EXACT (EIN (EXACT))
- Form D issuer: BIOCEPT INC EXACT (CIK (EXACT))
- SEC filer: BIOCEPT INC EXACT (CIK (EXACT))
Filings 70
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2013-09-23 | S-1 | S-1 (registration) | BIOCEPT INC | 0001193125-13-374871 ↗ |
| 2013-10-16 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001193125-13-401215 ↗ |
| 2013-11-05 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001193125-13-428005 ↗ |
| 2013-11-20 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001193125-13-447582 ↗ |
| 2013-11-22 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001193125-13-451475 ↗ |
| 2013-12-17 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001193125-13-476215 ↗ |
| 2014-01-08 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001193125-14-005556 ↗ |
| 2014-01-10 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001193125-14-007841 ↗ |
| 2014-01-30 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001193125-14-028341 ↗ |
| 2014-02-04 | S-1MEF | S-1MEF (added securities) | BIOCEPT INC | 0001193125-14-035586 ↗ |
| 2014-02-04 | EFFECT | EFFECT (declared effective) | BIOCEPT INC | 9999999995-14-000306 ↗ |
| 2014-02-06 | 424B4 | 424B4 (final prospectus) | BIOCEPT INC | 0001193125-14-037503 ↗ |
| 2015-01-09 | S-1 | S-1 (registration) | BIOCEPT INC | 0001564590-15-000099 ↗ |
| 2015-01-21 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0000950123-15-000339 ↗ |
| 2015-02-06 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001564590-15-000542 ↗ |
| 2015-02-09 | S-1MEF | S-1MEF (added securities) | BIOCEPT INC | 0000950123-15-001182 ↗ |
| 2015-02-09 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001564590-15-000560 ↗ |
| 2015-02-09 | EFFECT | EFFECT (declared effective) | BIOCEPT INC | 9999999995-15-000351 ↗ |
| 2015-02-10 | 424B4 | 424B4 (final prospectus) | BIOCEPT INC | 0001564590-15-000588 ↗ |
| 2015-05-21 | EFFECT | EFFECT (declared effective) | BIOCEPT INC | 9999999995-15-001433 ↗ |
| 2015-12-22 | S-1 | S-1 (registration) | BIOCEPT INC | 0000950123-15-012578 ↗ |
| 2016-01-21 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001193125-16-434595 ↗ |
| 2016-02-01 | EFFECT | EFFECT (declared effective) | BIOCEPT INC | 9999999995-16-003637 ↗ |
| 2016-05-10 | EFFECT | EFFECT (declared effective) | BIOCEPT INC | 9999999995-16-004598 ↗ |
| 2016-08-12 | S-1 | S-1 (registration) | BIOCEPT INC | 0001193125-16-680813 ↗ |
| 2016-09-29 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001193125-16-724715 ↗ |
| 2016-10-06 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001193125-16-731833 ↗ |
| 2016-10-12 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001193125-16-736008 ↗ |
| 2016-10-13 | EFFECT | EFFECT (declared effective) | BIOCEPT INC | 9999999995-16-005959 ↗ |
| 2016-10-14 | 424B4 | 424B4 (final prospectus) | BIOCEPT INC | 0001564590-16-025824 ↗ |
| 2017-08-30 | EFFECT | EFFECT (declared effective) | BIOCEPT INC | 9999999995-17-002232 ↗ |
| 2017-11-17 | S-1 | S-1 (registration) | BIOCEPT INC | 0000950123-17-011047 ↗ |
| 2017-11-21 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001193125-17-349265 ↗ |
| 2018-01-22 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001193125-18-016152 ↗ |
| 2018-01-24 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001193125-18-017911 ↗ |
| 2018-01-25 | EFFECT | EFFECT (declared effective) | BIOCEPT INC | 9999999995-18-000215 ↗ |
| 2018-01-26 | S-1MEF | S-1MEF (added securities) | BIOCEPT INC | 0001193125-18-020415 ↗ |
| 2018-01-26 | 424B4 | 424B4 (final prospectus) | BIOCEPT INC | 0001564590-18-000964 ↗ |
| 2018-05-23 | S-1 | S-1 (registration) | BIOCEPT INC | 0000950123-18-005962 ↗ |
| 2018-05-24 | EFFECT | EFFECT (declared effective) | BIOCEPT INC | 9999999995-18-001343 ↗ |
| 2018-07-11 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0000950123-18-006726 ↗ |
| 2018-07-20 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001564590-18-017061 ↗ |
| 2018-07-23 | EFFECT | EFFECT (declared effective) | BIOCEPT INC | 9999999995-18-001854 ↗ |
| 2018-07-24 | 424B4 | 424B4 (final prospectus) | BIOCEPT INC | 0001564590-18-017291 ↗ |
| 2018-10-19 | S-1 | S-1 (registration) | BIOCEPT INC | 0001564590-18-024533 ↗ |
| 2018-10-29 | EFFECT | EFFECT (declared effective) | BIOCEPT INC | 9999999995-18-002746 ↗ |
| 2018-11-28 | S-1 | S-1 (registration) | BIOCEPT INC | 0001564590-18-030163 ↗ |
| 2018-12-10 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001564590-18-030702 ↗ |
| 2018-12-19 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001564590-18-031070 ↗ |
| 2019-01-29 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001193125-19-020480 ↗ |
| 2019-02-07 | EFFECT | EFFECT (declared effective) | BIOCEPT INC | 9999999995-19-000116 ↗ |
| 2019-02-11 | 424B4 | 424B4 (final prospectus) | BIOCEPT INC | 0001564590-19-002442 ↗ |
| 2019-04-10 | S-1 | S-1 (registration) | BIOCEPT INC | 0001564590-19-011262 ↗ |
| 2019-04-17 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001564590-19-011765 ↗ |
| 2019-04-22 | EFFECT | EFFECT (declared effective) | BIOCEPT INC | 9999999995-19-000787 ↗ |
| 2019-11-04 | S-1 | S-1 (registration) | BIOCEPT INC | 0001564590-19-039452 ↗ |
| 2019-11-08 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001564590-19-042302 ↗ |
| 2019-11-15 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001564590-19-043650 ↗ |
| 2019-12-05 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001564590-19-045290 ↗ |
| 2019-12-06 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001564590-19-045408 ↗ |
| 2019-12-09 | EFFECT | EFFECT (declared effective) | BIOCEPT INC | 9999999995-19-002762 ↗ |
| 2019-12-11 | 424B4 | 424B4 (final prospectus) | BIOCEPT INC | 0001564590-19-045675 ↗ |
| 2020-05-08 | EFFECT | EFFECT (declared effective) | BIOCEPT INC | 9999999995-20-001095 ↗ |
| 2023-04-20 | S-1 | S-1 (registration) | BIOCEPT INC | 0001193125-23-108406 ↗ |
| 2023-05-15 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001193125-23-144138 ↗ |
| 2023-05-16 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001193125-23-146104 ↗ |
| 2023-05-19 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001193125-23-149430 ↗ |
| 2023-05-23 | S-1/A | S-1/A (amendment) | BIOCEPT INC | 0001193125-23-151164 ↗ |
| 2023-05-24 | EFFECT | EFFECT (declared effective) | BIOCEPT INC | 9999999995-23-001517 ↗ |
| 2023-05-25 | 424B4 | 424B4 (final prospectus) | BIOCEPT INC | 0001193125-23-154367 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| ARNOLD LYLE J | Officer | SR VP of R&D and CSO; SVP, Chief Scientific Officer | 9 | 2014–2019 | |
| Bischoff Farideh Z. | Officer | VICE PRESIDENT | 2 | 2014 | |
| Chandler Marsha Alpert | Director | 13 | 2014–2022 | ||
| Gerhardt Bruce | Director | 16 | 2014–2022 | ||
| HALE DAVID F | Director; Director,Officer | Chairman; CHAIRMAN; EXECUTIVE CHAIRMAN | 19 | 2014–2021 | |
| HUEBNER BRUCE A | Director | 10 | 2014–2020 | ||
| Kachioff William G | Officer | SVP, CFO AND SECRETARY | 3 | 2014 | |
| Nall Michael W. | Director,Officer | CEO AND PRESIDENT; CEO & President | 13 | 2014–2021 | |
| Neff Edward A. | Director | 10 | 2014–2017 | ||
| Reiss Claire | TenPercentOwner | 7 | 2014–2016 | ||
| ROYSTON IVOR | Director | 15 | 2014–2022 | ||
| Wilson Margaret Faye | Director | 14 | 2014–2022 | ||
| Trivedi Raaj | Officer | VP Commercial Operations; VP, COMMERCIAL OPERATIONS | 4 | 2014–2016 | |
| Singh Veena | Officer | Sr VP & Sr Med Director | 8 | 2014–2017 | |
| FOLETTA MARK G | Officer | Interim CFO | 2 | 2015 | |
| Kennedy Timothy | Officer | CFO, COO & Secretary; CFO, Sr V.P. Operations & Sec. | 8 | 2016–2021 | |
| Ally Bridge LB Healthcare Master Fund Ltd | TenPercentOwner | 3 | 2016–2017 | ||
| Ally Bridge LB Management Ltd | TenPercentOwner | 3 | 2016–2017 | ||
| Li Bin | TenPercentOwner | 3 | 2016–2017 | ||
| Yu Fan | TenPercentOwner | 3 | 2016–2017 | ||
| TERRY MICHAEL J | Officer | Sr VP Comm. Operations; Sr VP of Business Development | 5 | 2017–2021 | |
| Hendrick Edwin | Officer | SVP, Chief Commercial Officer | 3 | 2018–2019 | |
| Dunn Cory | Officer | Sr. VP Corp. Development | 1 | 2020 | |
| DUGAN MICHAEL C | Officer | Chief Med Off & Med. Director | 4 | 2020–2021 | |
| Riccitelli Samuel D | Director; Director,Officer | Interim President and CEO | 4 | 2020–2022 | |
| Morales Antonino | Director; Director,Officer | Interim CFO | 3 | 2021–2022 | |
| Rubinstein Linda M | Director | 3 | 2021–2022 | ||
| Marchand Philippe | Officer | Chief Operations Officer | 2 | 2022 | |
| Taylor Darrell | Officer | See remarks; Sr. V.P., General Counsel | 3 | 2022 | |
| DAO-HADDOCK QUYEN THI | Director | 2 | 2022 | ||
| Walsh Robert | Officer | VP, Controller | 1 | 2023 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2019-06-06 | BIOCEPT INC | Biotechnology | $10,134,300 | $0 | 7 | 1 |
| 2019-03-29 | BIOCEPT INC | Biotechnology | $7,437,500 | $0 | 7 | 1 |
| 2018-10-03 | BIOCEPT INC | Biotechnology | $2,409,304 | $0 | 4 | 1 |
| 2017-08-14 | BIOCEPT INC | Biotechnology | $4,351,958 | $2,200,000 | 1 | 1 |
| 2017-04-10 | BIOCEPT INC | Biotechnology | $5,400,000 | $0 | 13 | 1 |
| 2015-12-23 | BIOCEPT INC | Biotechnology | $15,000,000 | $1,000,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.